![Paul Tebbey](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul Tebbey
Direttore operativo presso Elusys Therapeutics, Inc.
Profilo
Paul W.
Tebbey is currently the Director at Radyus Research, Inc. and the Chief Operating Officer at Elusys Therapeutics, Inc. Previously, he held the position of Senior VP-Product Development & Portfolio Strategy at Scorpius Holdings, Inc. from 2021 to 2023.
He holds a doctorate degree from East Carolina University and an MBA from Rochester Institute of Technology.
Posizioni attive di Paul Tebbey
Società | Posizione | Inizio |
---|---|---|
Radyus Research, Inc.
![]() Radyus Research, Inc. Medical/Nursing ServicesHealth Services Radyus Research, Inc. provides healthcare services. The company is headquartered in Atlanta, GA. | Direttore/Membro del Consiglio | - |
Elusys Therapeutics, Inc.
![]() Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Direttore operativo | - |
Precedenti posizioni note di Paul Tebbey
Società | Posizione | Fine |
---|---|---|
SCORPIUS HOLDINGS, INC. | Corporate Officer/Principal | 01/01/2023 |
Formazione di Paul Tebbey
East Carolina University | Doctorate Degree |
Rochester Institute of Technology | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SCORPIUS HOLDINGS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Elusys Therapeutics, Inc.
![]() Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Health Technology |
Radyus Research, Inc.
![]() Radyus Research, Inc. Medical/Nursing ServicesHealth Services Radyus Research, Inc. provides healthcare services. The company is headquartered in Atlanta, GA. | Health Services |
- Borsa valori
- Insiders
- Paul Tebbey